Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (238)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
12
2025
511
1.270
 Why?
Germ-Line Mutation
9
2013
61
1.050
 Why?
Hamartoma Syndrome, Multiple
8
2012
14
1.050
 Why?
PTEN Phosphohydrolase
13
2015
53
1.020
 Why?
Barrett Esophagus
2
2019
30
0.990
 Why?
Esophageal Neoplasms
2
2019
106
0.910
 Why?
Adenocarcinoma
3
2019
397
0.820
 Why?
Haplotypes
3
2020
84
0.760
 Why?
Polymorphism, Single Nucleotide
9
2021
475
0.650
 Why?
Homozygote
3
2019
57
0.650
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
154
0.620
 Why?
Proto-Oncogene Proteins c-akt
4
2012
156
0.580
 Why?
Databases, Factual
1
2020
674
0.550
 Why?
Alleles
6
2021
256
0.450
 Why?
Lung Neoplasms
3
2020
600
0.440
 Why?
Phosphatidylinositol 3-Kinases
2
2012
140
0.410
 Why?
Genotype
6
2021
533
0.400
 Why?
Scavenger Receptors, Class A
1
2011
39
0.370
 Why?
Extracellular Matrix Proteins
1
2011
68
0.370
 Why?
Case-Control Studies
5
2025
1156
0.310
 Why?
Genetic Variation
3
2021
207
0.290
 Why?
Humans
38
2025
50509
0.290
 Why?
Transcription Factors
1
2011
565
0.290
 Why?
Breast Neoplasms
7
2017
1201
0.280
 Why?
Thyroid Neoplasms
4
2012
112
0.280
 Why?
Heart Defects, Congenital
2
2024
602
0.270
 Why?
Limb Deformities, Congenital
1
2025
14
0.240
 Why?
Genes, Wilms Tumor
1
2005
1
0.240
 Why?
Population
1
2005
9
0.240
 Why?
Gene Frequency
3
2020
97
0.240
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
13
0.240
 Why?
Genome
2
2019
65
0.230
 Why?
Lamin Type A
1
2024
6
0.230
 Why?
Female
22
2025
27086
0.220
 Why?
Capacity Building
1
2024
18
0.220
 Why?
Exome
2
2025
48
0.220
 Why?
DNA Methylation
3
2024
550
0.220
 Why?
Adult
16
2024
13583
0.210
 Why?
Linkage Disequilibrium
2
2020
36
0.210
 Why?
Middle Aged
16
2021
12614
0.210
 Why?
Smoke-Free Policy
1
2022
9
0.200
 Why?
Tobacco Smoke Pollution
1
2022
48
0.200
 Why?
Male
16
2025
25910
0.190
 Why?
Inheritance Patterns
1
2021
22
0.180
 Why?
Phenotype
7
2021
739
0.180
 Why?
Models, Genetic
5
2013
172
0.180
 Why?
Risk Factors
5
2019
3724
0.180
 Why?
Succinate Dehydrogenase
2
2011
22
0.170
 Why?
Stilbenes
2
2010
52
0.170
 Why?
Aged
11
2020
9743
0.170
 Why?
Fires
1
2020
14
0.170
 Why?
Agriculture
1
2020
19
0.170
 Why?
Tobacco Products
1
2021
126
0.160
 Why?
Social Media
1
2021
99
0.160
 Why?
Cluster Analysis
4
2013
218
0.160
 Why?
Aged, 80 and over
5
2020
3228
0.160
 Why?
Genomics
1
2020
279
0.150
 Why?
Cell Proliferation
3
2010
985
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
138
0.140
 Why?
Prostatic Neoplasms
2
2012
384
0.140
 Why?
Gene Expression Regulation, Neoplastic
3
2010
833
0.140
 Why?
Prognosis
2
2020
1978
0.140
 Why?
Endometrial Neoplasms
2
2015
137
0.130
 Why?
Leprosy
1
2016
5
0.130
 Why?
Asthma
1
2020
284
0.130
 Why?
Hypertension
1
2021
544
0.130
 Why?
Emergency Service, Hospital
1
2020
484
0.130
 Why?
Microsatellite Repeats
2
2012
37
0.120
 Why?
Regression Analysis
2
2017
382
0.120
 Why?
Aromatase
1
2015
8
0.120
 Why?
Tuberculosis
1
2016
130
0.120
 Why?
Arkansas
4
2024
1984
0.120
 Why?
Genetic Linkage
2
2011
26
0.110
 Why?
Young Adult
7
2021
4106
0.110
 Why?
Adolescent
8
2021
6447
0.110
 Why?
Sirolimus
2
2010
62
0.110
 Why?
Genome-Wide Association Study
2
2012
163
0.110
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
1
0.110
 Why?
Smad4 Protein
1
2013
5
0.110
 Why?
Genetic Testing
2
2010
120
0.100
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
17
0.100
 Why?
Cohort Studies
3
2012
1452
0.100
 Why?
Colonic Polyps
1
2013
37
0.100
 Why?
Mitochondrial Diseases
1
2012
41
0.100
 Why?
Receptors, Cell Surface
1
2013
116
0.100
 Why?
Codon, Nonsense
1
2012
26
0.100
 Why?
Flavin-Adenine Dinucleotide
1
2011
4
0.100
 Why?
NAD
1
2011
41
0.090
 Why?
Antigens, CD
1
2013
222
0.090
 Why?
Genes, p53
1
2011
49
0.090
 Why?
DNA, Neoplasm
1
2012
143
0.090
 Why?
Siblings
1
2011
33
0.090
 Why?
Mutation, Missense
1
2012
103
0.090
 Why?
Gene Expression Profiling
3
2012
1025
0.090
 Why?
Taxoids
1
2011
37
0.090
 Why?
Adenoma
1
2012
113
0.090
 Why?
Risk
1
2012
324
0.090
 Why?
Software
1
2013
277
0.090
 Why?
Intestinal Polyps
1
2010
7
0.090
 Why?
Colorectal Neoplasms
2
2012
260
0.090
 Why?
Receptors, Androgen
1
2010
45
0.090
 Why?
Cephalometry
1
2010
18
0.090
 Why?
Tumor Microenvironment
1
2012
222
0.080
 Why?
Head
1
2010
71
0.080
 Why?
Gene Dosage
1
2009
74
0.080
 Why?
Carcinoma, Transitional Cell
1
2010
51
0.080
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
135
0.080
 Why?
Patient Selection
1
2010
259
0.080
 Why?
Cell Communication
1
2009
68
0.080
 Why?
Drug Resistance, Neoplasm
1
2011
316
0.080
 Why?
Age Factors
1
2012
1110
0.080
 Why?
Urinary Bladder Neoplasms
1
2010
158
0.080
 Why?
Immunohistochemistry
1
2011
957
0.080
 Why?
Smoking
1
2012
507
0.070
 Why?
Prevalence
2
2021
971
0.070
 Why?
Chromosome Mapping
2
2021
153
0.070
 Why?
Prospective Studies
4
2017
2378
0.070
 Why?
Mass Screening
1
2010
344
0.070
 Why?
Rural Population
2
2022
555
0.070
 Why?
Cell Line, Tumor
4
2011
1398
0.070
 Why?
Physical Chromosome Mapping
1
2005
8
0.060
 Why?
Multiple Myeloma
1
2020
2997
0.060
 Why?
Antineoplastic Agents
2
2011
1172
0.060
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
3
0.060
 Why?
DNA Copy Number Variations
1
2025
109
0.060
 Why?
Exons
1
2005
93
0.060
 Why?
Child
5
2020
6910
0.060
 Why?
CpG Islands
1
2024
108
0.060
 Why?
Models, Theoretical
1
2005
170
0.060
 Why?
Gene Expression Regulation
1
2008
955
0.050
 Why?
Mutation
2
2010
1281
0.050
 Why?
Biopsy
1
2005
588
0.050
 Why?
Polyproteins
1
2022
2
0.050
 Why?
Child, Preschool
3
2020
3944
0.050
 Why?
RNA, Viral
1
2022
107
0.050
 Why?
Risk Assessment
2
2021
1270
0.050
 Why?
Phosphoproteins
1
2022
115
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
5
0.050
 Why?
United States Food and Drug Administration
1
2021
90
0.050
 Why?
Membrane Glycoproteins
1
2022
245
0.050
 Why?
Azacitidine
1
2020
34
0.040
 Why?
Nutrition Surveys
1
2021
113
0.040
 Why?
Loss of Heterozygosity
2
2012
75
0.040
 Why?
United States
2
2021
4958
0.040
 Why?
Stromal Cells
2
2012
75
0.040
 Why?
Nicotine
1
2021
184
0.040
 Why?
TOR Serine-Threonine Kinases
2
2010
78
0.040
 Why?
Self Report
1
2021
206
0.040
 Why?
Pedigree
2
2010
119
0.040
 Why?
Seasons
1
2020
79
0.040
 Why?
Neoplasms
1
2009
1254
0.040
 Why?
Signal Transduction
3
2010
1624
0.040
 Why?
Odds Ratio
1
2021
551
0.040
 Why?
Air Pollution
1
2020
46
0.040
 Why?
Phosphorylation
2
2010
525
0.040
 Why?
Gene Expression
2
2012
610
0.040
 Why?
Sensitivity and Specificity
2
2012
861
0.040
 Why?
Predictive Value of Tests
2
2012
929
0.040
 Why?
Dexamethasone
1
2020
432
0.040
 Why?
Treatment Outcome
2
2020
5285
0.040
 Why?
Infant
2
2020
3630
0.030
 Why?
Angiopoietin-2
1
2017
15
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Dose-Response Relationship, Drug
2
2010
1372
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
45
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
181
0.030
 Why?
Cross-Sectional Studies
1
2021
1609
0.030
 Why?
Neovascularization, Pathologic
1
2017
155
0.030
 Why?
Neoadjuvant Therapy
1
2017
120
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
48
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1000
0.030
 Why?
Pilot Projects
1
2016
699
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
88
0.030
 Why?
Genome, Human
1
2013
109
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Penetrance
1
2012
6
0.020
 Why?
Neoplasm Grading
1
2012
122
0.020
 Why?
Genetic Association Studies
1
2012
119
0.020
 Why?
Vincristine
1
2011
82
0.020
 Why?
Anthracyclines
1
2011
29
0.020
 Why?
Inhibitory Concentration 50
1
2010
69
0.020
 Why?
Paclitaxel
1
2011
84
0.020
 Why?
Formazans
1
2010
4
0.020
 Why?
Tetrazolium Salts
1
2010
14
0.020
 Why?
Immunoblotting
1
2010
115
0.020
 Why?
Androgen Antagonists
1
2010
11
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
80
0.020
 Why?
Drug Synergism
1
2010
151
0.020
 Why?
HEK293 Cells
1
2011
213
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
155
0.020
 Why?
Michigan
1
2010
19
0.020
 Why?
Epithelial Cells
1
2012
207
0.020
 Why?
Point Mutation
1
2010
62
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
17
0.020
 Why?
Kidney Neoplasms
1
2012
174
0.020
 Why?
Neoplasm Transplantation
1
2010
86
0.020
 Why?
Androgens
1
2010
70
0.020
 Why?
Transplantation, Heterologous
1
2010
75
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
BRCA2 Protein
1
2009
16
0.020
 Why?
Adenosine Triphosphate
1
2011
232
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
75
0.020
 Why?
Comparative Genomic Hybridization
1
2009
43
0.020
 Why?
BRCA1 Protein
1
2009
32
0.020
 Why?
Polymerase Chain Reaction
1
2011
449
0.020
 Why?
Proteins
1
2012
339
0.020
 Why?
Mice, Nude
1
2010
248
0.020
 Why?
Chi-Square Distribution
1
2010
277
0.020
 Why?
Cell Cycle
1
2010
226
0.020
 Why?
Algorithms
1
2013
628
0.020
 Why?
Protein Binding
1
2011
654
0.020
 Why?
Gene Deletion
1
2010
261
0.020
 Why?
Diagnosis, Differential
1
2012
1033
0.020
 Why?
Cell Survival
1
2010
589
0.020
 Why?
Neoplasm Invasiveness
1
2009
269
0.020
 Why?
Neoplastic Stem Cells
1
2009
98
0.020
 Why?
Incidence
1
2012
1032
0.020
 Why?
Promoter Regions, Genetic
1
2010
465
0.020
 Why?
Membrane Proteins
1
2010
332
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
181
0.020
 Why?
Neoplasm Staging
1
2011
746
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
405
0.020
 Why?
Microscopy, Confocal
1
2008
83
0.020
 Why?
Cell Differentiation
1
2011
640
0.020
 Why?
Chromosome Aberrations
1
2009
280
0.020
 Why?
Survival Rate
1
2010
909
0.020
 Why?
Registries
1
2010
563
0.020
 Why?
Chromosomes, Human
1
2005
39
0.020
 Why?
Time Factors
1
2010
2934
0.010
 Why?
Reproducibility of Results
1
2005
1199
0.010
 Why?
Mice
1
2010
5687
0.010
 Why?
Animals
1
2010
13124
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (238) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department